Mardepodect

DB08387InvestigationalSmall molecule

Mardepodect: Overview.

Mechanism: Pharmacologically active on cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Curator reviewed
Formula / weight: C₂₅H₂₀N₄O · 392.4525 g/mol (avg)
Also known as: 2-[4-(1-Methyl-4-pyridin-4-yl-lH-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid
Code names: MP-10 · PF-02545920 · PF-0254920 · PF 2545920

Resolves to

Compound

Structure

InChIKeyAZEXWHKOMMASPA-UHFFFAOYSA-NSMILESCN1C=C(C(=N1)C1=CC=C(OCC2=NC3=CC=CC=C3C=C2)C=C1)C1=CC=NC=C1

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mardepodect, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.